National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 75357 [2013-29468]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 238 / Wednesday, December 11, 2013 / Notices
development of evidence-based
guidelines and tested/validated
intervention tools; (5) training
professionals; and (6) building capacity
for systems of services in states.
Likely Respondents: Grantees funded
by HRSA under the CAAI will be the
respondents for this data collection
activity. The programs to be evaluated
are listed below.
• 20 R40 Maternal and Child Health
(MCH) Autism Intervention Research
Program grantees that support research
on evidence-based practices for
interventions to improve the health and
well-being of children and adolescents
with ASD and other DD.
3. State Implementation Program
Grants for Improving Services for
Children and Youth With ASD and
Other DD
1. Training Programs
• Nine grantees will implement state
• Leadership Education in
autism plans and develop models for
Neurodevelopmental Disabilities
improving the system of care for
(LEND) training programs with fortychildren and youth with ASD and other
three grantees;
• Developmental Behavioral
DD;
• Four grantees will design state
Pediatrics (DBP) training programs with
plans for improving the system for
ten grantees; and
• A National Combating Autism
children and youth with ASD and other
Interdisciplinary Training Resource
DDs; and
• A State Public Health Coordinating
Center grantee.
Resource Center grantee.
2. Research Networks Program
The data gathered through this
• Three Autism Intervention Research evaluation will be used to:
• Evaluate the grantees’ performance
Networks that focus on intervention
in achieving the objectives of the CAAI
research, guideline development, and
during the three year grant period;
information dissemination; and
75357
• Assess the short- and intermediateterm impacts of the grant programs on
children and families affected by ASD
and other DD; and
• Measure the CAAI outputs and
outcomes for the Report to Congress.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions; to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information; to search
data sources; to complete and review
the collection of information; and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Grant program/form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total
responses
Total burden
hours
LEND interview Protocol ..................................................
DBP Interview Protocol ....................................................
State Implementation Program Interview Protocol 1 ........
State Implementation Program Questionnaire ................
Research Network Interview Protocol .............................
Research Program R40 Interview Protocol .....................
Research Network Questionnaire ....................................
Resource Centers Interview Protocol ..............................
43
10
13
13
3
20
3
2
1
1
1
1
1
1
1
1
43
10
13
13
3
20
3
2
1
1
1
.75
1
1
3
1
43
10
13
9.75
3
20
9
2
Total ..........................................................................
107
........................
107
..........................
109.75
1 Although
a total of 22 state grants have been awarded to date, states that were awarded grants in 2008 and 2009 were interviewed during
the previous evaluation. We are seeking clearance to interview only the 13 states that were awarded grants in 2011.
Dated: December 5, 2013.
Bahar Niakan,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2013–29509 Filed 12–10–13; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
emcdonald on DSK67QTVN1PROD with NOTICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
VerDate Mar<15>2010
17:00 Dec 10, 2013
Jkt 232001
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID SBIR Phase II
Clinical Trial Implementation Cooperative
Agreement (U44) and Clinical Trial Planning
Grant (R34).
Date: January 7, 2014.
Time: 12:00 p.m. to 4:00 p.m.
PO 00000
Frm 00029
Fmt 4703
Sfmt 9990
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3131, 6700–B Rockledge Drive, Bethesda, MD
20892, (Telephone Conference Call).
Contact Person: Betty Poon, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
NIAID/NIH/DHHS, 6700B Rockledge Drive,
MSC 7616, Bethesda, MD 20892–7616, 301–
402–6891, poonb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS).
Dated: December 4, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–29468 Filed 12–10–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\11DEN1.SGM
11DEN1
]]>Agencies
[Federal Register Volume 78, Number 238 (Wednesday, December 11, 2013)]
[Notices]
[Page 75357]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-29468]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial
Implementation Cooperative Agreement (U44) and Clinical Trial
Planning Grant (R34).
Date: January 7, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Room 3131, 6700-B
Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Betty Poon, Ph.D., Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892-7616,
301-402-6891, poonb@mail.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS).
Dated: December 4, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-29468 Filed 12-10-13; 8:45 am]
BILLING CODE 4140-01-P
